Wang, Xm., Xie, Zf. Clinical study of the effect of Wuzi Yanzong Solution (五子衍宗液) for retarding senility., CJIM 1, 184–188 (1995). https://doi.org/10.1007/BF02942932
Wang Xue-mei, Xie Zhu-fan. Clinical study of the effect of Wuzi Yanzong Solution (五子衍宗液) for retarding senility. [J]. Chinese Journal of Integrative Medicine 1(3):184-188(1995)
Wang, Xm., Xie, Zf. Clinical study of the effect of Wuzi Yanzong Solution (五子衍宗液) for retarding senility., CJIM 1, 184–188 (1995). https://doi.org/10.1007/BF02942932DOI:
Wang Xue-mei, Xie Zhu-fan. Clinical study of the effect of Wuzi Yanzong Solution (五子衍宗液) for retarding senility. [J]. Chinese Journal of Integrative Medicine 1(3):184-188(1995) DOI: 10.1007/BF02942932.
Clinical study of the effect of Wuzi Yanzong Solution (五子衍宗液) for retarding senility
摘要
Eighty elderly men with symptoms of senility due to deficiency syndrome of the Kidney
but otherwise healthy
were randomly divided into two groups: one group was treated with Wuzi Yanzong Solution (WXYZS) and the other with a placebo
each for five weeks. After treatment
the symptoms of senility were ameliorated as judged by using a scoring method
the activity of the erythrocyte superoxide dismutase was increased
the plasma lipid peroxide content was reduced
the plasma testosterone level was raised and the plasma estradiol/testosterone ratio was decreased in the WZYZS group
while no changes were noticed in the placebo group. The results suggest that WZYS retard senility in the aged
probably through its action of eliminating free radicals
reducing plasma lipid peroxide levels
elevating erythrocyte superoxide dismutase activity and regulating sex hormone levels.
Abstract
Eighty elderly men with symptoms of senility due to deficiency syndrome of the Kidney
but otherwise healthy
were randomly divided into two groups: one group was treated with Wuzi Yanzong Solution (WXYZS) and the other with a placebo
each for five weeks. After treatment
the symptoms of senility were ameliorated as judged by using a scoring method
the activity of the erythrocyte superoxide dismutase was increased
the plasma lipid peroxide content was reduced
the plasma testosterone level was raised and the plasma estradiol/testosterone ratio was decreased in the WZYZS group
while no changes were noticed in the placebo group. The results suggest that WZYS retard senility in the aged
probably through its action of eliminating free radicals
reducing plasma lipid peroxide levels
elevating erythrocyte superoxide dismutase activity and regulating sex hormone levels.